Bellicum Pharmaceuticals, located near the Houston Medical Center, is engineering high-performance cellular immunotherapies and unleashing their power against a wide range of cancers, impacting more patients than ever. Our cellular platform technology is designed to break through significant clinical barriers and activate the full power of cellular immunotherapies, with a focus on chimeric antigen receptor T-cell therapy (CAR-T).